hydroxyurea has been researched along with Incontinentia Pigmenti Achromians in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day." | 5.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| " Acral erythema is another cutaneous side effect that is relatively specific to chemotherapy and is often dose-related." | 2.42 | Mucocutaneous side effects of antineoplastic chemotherapy. ( Bessis, D; Dereure, O; Guillot, B, 2004) |
| "Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day." | 1.31 | Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002) |
| "Hydroxyurea is an effective agent in the treatment of chronic myelogenous leukemia." | 1.25 | Skin changes secondary to hydroxyurea therapy. ( Goltz, RW; Kennedy, BJ; Smith, LR, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, AL | 1 |
| Körver, JE | 1 |
| Theunissen, CC | 1 |
| Ranta, D | 1 |
| Bonmati, C | 1 |
| Serrano-Falcón, C | 1 |
| Pugnaire, MAF | 1 |
| Del Mar Serrano-Falcón, M | 1 |
| Morales, MG | 1 |
| Serrano-Ortega, S | 1 |
| Clerico, R | 1 |
| Corsetti, P | 1 |
| Ambrifi, M | 1 |
| Paolino, G | 1 |
| Rossi, MR | 1 |
| Bottoni, U | 1 |
| Calvieri, S | 1 |
| Oh, ST | 1 |
| Lee, DW | 1 |
| Lee, JY | 1 |
| Cho, BK | 1 |
| SEARS, ME | 1 |
| Guillot, B | 1 |
| Bessis, D | 1 |
| Dereure, O | 1 |
| Konrad, H | 1 |
| Wollina, U | 1 |
| Teo, RY | 1 |
| Tan, E | 1 |
| Delmas-Marsalet, B | 1 |
| Beaulieu, P | 1 |
| Teillet-Thiebaud, F | 1 |
| Jary, L | 1 |
| Teillet, F | 1 |
| Cakir, B | 1 |
| Sucak, G | 1 |
| Haznedar, R | 1 |
| Kumar, B | 1 |
| Saraswat, A | 1 |
| Kaur, I | 1 |
| Kennedy, BJ | 1 |
| Smith, LR | 1 |
| Goltz, RW | 1 |
| Kelsey, PR | 1 |
| Vomvouras, S | 1 |
| Pakula, AS | 1 |
| Shaw, JM | 1 |
| Majumdar, G | 1 |
| Heard, SE | 1 |
| Slater, NG | 1 |
| Levantine, A | 1 |
| Almeyda, J | 1 |
| Lèques, B | 1 |
| Texier, L | 1 |
| Verdaguer, J | 1 |
3 reviews available for hydroxyurea and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Mucocutaneous side effects of antineoplastic chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Drug Eruptions; Hidradenitis; Humans; Hydroxyurea; Mucous Membrane; | 2004 |
Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hydroxyurea; Melanins; Middle Aged; Nail Diseases; P | 1995 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlor | 1974 |
15 other studies available for hydroxyurea and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Longitudinal melanonychia on multiple nails induced by hydroxyurea.
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Nail Diseases; Pigmentation Disorders; Pol | 2017 |
Images in clinical medicine. Acquired melanonychia.
Topics: Aged, 80 and over; Diagnosis, Differential; Female; Humans; Hydroxyurea; Nail Diseases; Pigmentation | 2009 |
Toxicoderma caused by hydroxyurea.
Topics: Aged; Drug Eruptions; Female; Humans; Hydroxyurea; Nail Diseases; Pigmentation Disorders; Skin Ulcer | 2011 |
Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
Topics: Aged; Diagnosis, Differential; Female; Humans; Hydroxyurea; Nail Diseases; Nucleic Acid Synthesis In | 2012 |
Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
Topics: Adolescent; Adult; Antineoplastic Agents; Dermatomyositis; Drug Eruptions; Humans; Hydroxyurea; Leuk | 2003 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
Topics: Anemia; Anemia, Myelophthisic; Antineoplastic Agents; Breast Neoplasms; Drug Therapy; Erythema; Estr | 1964 |
[Black discoloration of nails in polycythaemia vera].
Topics: Aged; Antineoplastic Agents; Biopsy, Needle; Diagnosis, Differential; Female; Humans; Hydroxyurea; N | 2005 |
A case of hydroxyurea-induced transverse melanonychia.
Topics: Adult; Female; Humans; Hydroxyurea; Nail Diseases; Pigmentation Disorders; Thrombocytosis; Vision Di | 2006 |
Longitudinal pigmented nail bands during hydroxyurea therapy.
Topics: Antineoplastic Agents; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1997 |
Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.
Topics: Adult; Aged; Drug Eruptions; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Icht | 2002 |
Skin changes secondary to hydroxyurea therapy.
Topics: Administration, Oral; Adult; Biopsy; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Leukocyte Count | 1975 |
Multiple longitudinal pigmented nail bands during hydroxyurea therapy.
Topics: Aged; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic-Phase; Melanocytes; Nail Diseases; Pig | 1992 |
Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding.
Topics: Aged; Female; Fingers; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nail D | 1991 |
Reversible hyperpigmentation associated with high dose hydroxyurea.
Topics: Humans; Hydroxyurea; Male; Middle Aged; Pigmentation Disorders | 1990 |
[Inflammatory livedo and idiopathic thrombocythemia. Remarkable therapeutic action of hydroxyurea].
Topics: Humans; Hydroxyurea; Male; Middle Aged; Pigmentation Disorders; Skin Manifestations; Thrombocytosis | 1967 |